[April 11, 2016]

Genome Editing: $2 Billion Technologies and Global Markets Opportunity by 2020 - Research and Markets

Research and Markets has announced the addition of the "Genome Editing: Technologies and Global Markets" report to their offering.

The global market for genome editing totaled $206.0 million in 2014 and $395.0 million in 2015. The market should total over $2.0 billion by 2020, growing at a compound annual growth rate (CAGR) of 38.9% from 2015 to 2020.

This report provides detailed market and industry analyses of the rapidly growing global market for genome editing. Important trends of the field and market segments are identified, and market sizes and sales forecasts by segmented markets are provided through 2020.

This study is focused on the market side of genome editing, along with a comprehensive review of genome editing technologies with related latest progresses in the field. Different market segments for this specific market are covered. For example, application-based market segments include academic research, drug development, clinical therapy, non-transgenic breeding and other applications; and regional market segments include the U.S., Europe, Asia-Pacific and Rest of World.

Specifically, centered on the market itself and its environment, this report covers almost all aspects of the global genome editing industry, including its technologies, applications and markets, which are further segmented and analyzed by region, product type, application and technology. The report forecasts the sizes and trends of the global market as well as its each segment. It details recent technical breakthroughs as well as major technical issues to overcome before the genome editing is applied to clinic applications. The growth driving factors and the factors that may limit the market's growth ar identified.

The ethical issues, regulatory issues and intellectual property right issues are discussed. The trends of patent publications, research publications and research funding in the genome editing area are analyzed. A competitive landscape, including various growth strategies and opportunities, are discussed. Comprehensive company profiles of the major players in the current genome editing field are also included in this report. In addition, the contract services market and clinical applications market are also discussed.

Highlights:

- The global market for genome editing totaled $206.0 million in 2014 and $395.0 million in 2015. The market should total over $2.0 billion by 2020, growing at a compound annual growth rate (CAGR) of 38.9% from 2015 to 2020.

- The U.S. market for genome editing totaled $151.0 million in 2015, and should total $806.0 million by 2020, growing at a CAGR of 39.8% from 2015 to 2020.

- The genome editing market in European totaled $116.0 million in 2015 and should total $568.0 million by 2020 at a CAGR of 37.4% from 2015 to 2020

Key Topics Covered:

Chapter 1: Introduction

Chapter 2: Market Summary

Chapter 3: Current Genome Editing Technologies

Chapter 4: Applications of Genome Editing

Chapter 5: Market Segmentation and Forecast

Chapter 6: Contract Services Market Analysis

Chapter 7: Research Market Analysis

Chapter 8: Drug Development Market Analysis

Chapter 9: Agricultural Biotechnology Market Analysis

Chapter 10: Clinical Market Analysis

Chapter 11: Competition Landscape and Opportunities

Chapter 12: Factors Influencing the Genome Editing Market

Chapter 13: Company Profiles

- Addgene

- Agilent Technologies (News - Alert) Inc.

- Applied StemCell Inc.

- AstraZeneca

- Calyxt

- Caribou Biosciences

- Cellecta Inc.

- Cellectis SA

- CIBUS

- Clontech Laboratories

- CRISPR Therapeutics

- Editas Medicine

- GE Healthcare Dharmacon

- Genecopoeia

- Genscript

- Horizon Discovery

- Innovative Genomics Initiative

- Intellia Therapeutics Inc.

- Integrated DNA Technologies

- Ixcells Biotechnologies

- Juno Therapeutics

- Lonza

- New England Biolabs

- Nova Synthetix

- Origene Technologies

- Precision Biosciences Inc.

- Recombinetics

- Regeneron Pharmaceuticals Inc.

- Sangamo Biosciences

- SIGMA-Aldrich Corp.

- Thermo Fisher Scientific

- Toolgen Inc.

- Trans Genic Inc.

- Transomic Technologies Inc.

- Transposagen Biopharmaceuticals Inc.

For more information visit http://www.researchandmarkets.com/research/k8c7pz/genome_editing

View source version on businesswire.com: http://www.businesswire.com/news/home/20160411005668/en/

[ Back To TMCnet.com's Homepage ]